Boehringer Ingleheim

Related by string. * : Boehringer Ingelheim GmbH . Boehringer Ingelheim MedImmune . Boehringer Mannheim . Boehringer Ingelheim Roxane . Boehringer Ingelheim Centocor . Boehringer Ingelheim Vetmedica . Boehringer Ingelheim Pradaxa . Bayer Boehringer Ingelheim . Boehringer Ingelheim Pharmaceuticals . Boehringer Ingelheim Spiriva . Boehringer Ingelheim BI / : * *

Related by context. Frequent words. (Click for all words.) 61 Therapeutic Competitors Report 59 Merz Pharmaceuticals 58 Initiates Phase II 58 Tibotec Pharmaceuticals Ltd. 58 Sign License Agreement 58 Receives Orphan Drug Designation 57 Janssen Ortho Inc. 57 gets USFDA nod 57 Announces Licensing Agreement 57 Neuronetics 56 Completes Patient Enrollment 56 Enrolls First 56 Prometheus Laboratories 55 Announces FDA Clearance 55 Signs Licensing Agreement 55 reuptake inhibitor 55 Wyeth Ayerst 55 Pharma AG 55 Temsirolimus 54 TeGenero AG 54 Vidaza R 54 NV Organon 54 Berlex Laboratories 54 Onconase 54 Activase 54 intra nasal 53 Announces Immediate Availability 53 Eli Lily 53 AFFiRiS 53 UCB Pharma 53 Presents Positive 53 Sporanox 53 Metadate 53 Remicade infliximab 53 AstraZeneca Bristol Myers 53 Signs License Agreement 53 Altana Pharma 53 FDA Clears 53 GmbH verantwortlich 53 thetreatment 53 TAP Pharmaceuticals 53 Grünenthal 53 HIV integrase inhibitor 53 Develop Novel 52 Actelion Pharmaceuticals 52 orally disintegrating tablets 52 Fluconazole 52 Teijin Pharma 52 Aggrastat 52 Submits Application 52 PRIALT 52 Prism Pharmaceuticals 52 fostamatinib 52 Pharma GmbH 52 Neovastat 52 Saforis 52 Inhalation Aerosol 52 Completes Enrollment 52 Metabolic Disease 52 Collaborates With 52 Aliskiren 52 Corixa Corporation 52 PHARMACEUTICALS 51 Diabetic Neuropathy 51 Astex Therapeutics 51 Bayer AG BAY GY 51 Vivecon 51 Accolate 51 Strengthens Position 51 Boehringer Mannheim 51 Anti Infective 51 Accessed #/#/# [001] 51 Amira Pharmaceuticals 51 Acquires Exclusive 51 MERREM 51 orally disintegrating tablet 51 Meets Primary Endpoint 51 Retavase 51 Immune Tolerance Network 51 Drug Candidate 51 #-# Full Text 51 SWOT Analysis Aarkstore Enterprise 51 Nova Biomedical 51 Medtronics 51 Completes Merger With 51 Vascugel ® 51 Ortho McNeil Pharmaceuticals 51 Noxafil 51 Biopharm 51 Zelos Therapeutics 51 etamp 51 Raptiva ® 51 Cryopyrin Associated Periodic Syndromes 51 #:#-# [006] 50 Expands Relationship With 50 Paroxetine 50 Abbot Laboratories 50 Ascenta Therapeutics 50 Anti infective 50 ophthalmics 50 Corp. Nasdaq GENZ

Back to home page